These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The role of pharmacogenetics in the treatment of depression and anxiety disorders. Schosser A; Kasper S Int Clin Psychopharmacol; 2009 Nov; 24(6):277-88. PubMed ID: 19738481 [TBL] [Abstract][Full Text] [Related]
7. Antidepressant-dependent mRNA changes in mouse associated with hippocampal neurogenesis in a mouse model of depression. Malki K; Lourdusamy A; Binder E; Payá-Cano J; Sluyter F; Craig I; Keers R; McGuffin P; Uher R; Schalkwyk LC Pharmacogenet Genomics; 2012 Nov; 22(11):765-76. PubMed ID: 23026812 [TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics in depression and antidepressants. Bondy B Dialogues Clin Neurosci; 2005; 7(3):223-30. PubMed ID: 16156381 [TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetic considerations for late life depression therapy. Pitychoutis PM; Kokras N; Sanoudou D; Dalla C; Papadopoulou-Daifoti Z Expert Opin Drug Metab Toxicol; 2013 Aug; 9(8):989-99. PubMed ID: 23641676 [TBL] [Abstract][Full Text] [Related]
10. From monoamines to genomic targets: a paradigm shift for drug discovery in depression. Wong ML; Licinio J Nat Rev Drug Discov; 2004 Feb; 3(2):136-51. PubMed ID: 15040578 [TBL] [Abstract][Full Text] [Related]
11. The neurobiology of depression and antidepressant action. Willner P; Scheel-Krüger J; Belzung C Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 1):2331-71. PubMed ID: 23261405 [TBL] [Abstract][Full Text] [Related]
12. Progress and prospects in pharmacogenetics of antidepressant drugs. Fabbri C; Crisafulli C; Calabrò M; Spina E; Serretti A Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1157-68. PubMed ID: 27310483 [TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies. Lett TA; Walter H; Brandl EJ CNS Drugs; 2016 Dec; 30(12):1169-1189. PubMed ID: 27752945 [TBL] [Abstract][Full Text] [Related]
14. Gene expression: biomarker of antidepressant therapy? Menke A Int Rev Psychiatry; 2013 Oct; 25(5):579-91. PubMed ID: 24151803 [TBL] [Abstract][Full Text] [Related]
15. Brain-derived neurotrophic factor and antidepressant action: another piece of evidence from pharmacogenetics. Tsai SJ; Hong CJ; Liou YJ Pharmacogenomics; 2008 Sep; 9(9):1353-8. PubMed ID: 18781861 [TBL] [Abstract][Full Text] [Related]
17. Integrative physiology of depression and antidepressant drug action: implications for serotonergic mechanisms of action and novel therapeutic strategies for treatment of depression. Hale MW; Raison CL; Lowry CA Pharmacol Ther; 2013 Jan; 137(1):108-18. PubMed ID: 23017938 [TBL] [Abstract][Full Text] [Related]
18. Does minocycline have antidepressant effect? Pae CU; Marks DM; Han C; Patkar AA Biomed Pharmacother; 2008 Jun; 62(5):308-11. PubMed ID: 18267354 [TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics of antidepressant and mood-stabilizing drugs: a review of candidate-gene studies and future research directions. Lerer B; Macciardi F Int J Neuropsychopharmacol; 2002 Sep; 5(3):255-75. PubMed ID: 12366879 [TBL] [Abstract][Full Text] [Related]
20. European Group for the Study of Resistant Depression (GSRD)--where have we gone so far: review of clinical and genetic findings. Schosser A; Serretti A; Souery D; Mendlewicz J; Zohar J; Montgomery S; Kasper S Eur Neuropsychopharmacol; 2012 Jul; 22(7):453-68. PubMed ID: 22464339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]